Han Biomedical Inc.

Han Biomedical Inc. is a biotechnology company focused on the research, development, and production of advanced biomaterials for tissue repair and regeneration. The firm's primary purpose is to address unmet medical needs in the fields of reconstructive and regenerative medicine by offering innovative healthcare solutions. Its core product portfolio includes BarriGel, an anti-adhesion gel designed to prevent post-surgical adhesions; HANBIO Patient Lubricant for clinical and patient applications; HANCARE Collagen Matrix, a wound dressing made from high-quality collagen; HANBIO Gauze infused with collagen; and LEOFOR Hyaluronic Acid Solution used in tissue healing processes. Han Biomedical Inc.'s solutions are built on naturally derived materials and are tailored for use in surgeries and other medical procedures that require tissue reconstruction, particularly in orthopedics, gynecology, and general surgery. Through its commitment to market-driven research and development, the company aims to fulfill the needs of healthcare professionals and patients alike, positioning itself as an innovator in Taiwan's rapidly growing biotechnology sector. By prioritizing collaboration with clinicians and patient outcomes, Han Biomedical Inc. plays a significant role in advancing medical material technology and supporting the broader health technology ecosystem.